Can-Fite BioPharma Ltd.
CANF· NYSE
Can-Fite BioPharma Ltd.
- Last sale
- Oct 2, 2026 · -1.33%
- Market cap
- $2.91M
- 1.31M shares
- Filings
- 860
Price
Oct 2, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $405,000 | reported | |
| FY 2024 | 2024-12-31 | $674,000 | reported | |
| FY 2023 | 2023-12-31 | $743,000 | reported | |
| FY 2022 | 2022-12-31 | $810,000 | reported | |
| FY 2021 | 2021-12-31 | $853,000 | reported | |
| FY 2020 | 2020-12-31 | $763,000 | reported | |
| FY 2019 | 2019-12-31 | $2,032,000 | reported | |
| FY 2018 | 2018-12-31 | $3,820,000 | reported | |
| FY 2017 | 2017-12-31 | $789,000 revised | reported | |
| FY 2016 | 2016-12-31 | $165,000 | reported |
Can-Fite BioPharma Ltd. · CIK 1536196 · Engraved from SEC EDGAR
